Rosuvastatin
Overview
Rosuvastatin is a lipid regulating drug, belongs to statins. Rosuvastatin is a selective, competitive inhibitor of HMG-CoA reductase, an enzyme involved in the synthesis of cholesterol in the liver. Rosuvastatin is used in the treatment of primary hypercholesterolaemia, mixed dyslipidaemias or homozygous familial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate measures. Statins are more effective than other classes in lowering the LDL-cholesterol, they reduce coronary events, all cardiovascular events, and total mortality.
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Back to top
Back to top
Side Effects
Back to top
Dosage
Rosuvastatin's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 5 to 20 mg/day | 12 (12.5) | As recommended. | PO | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Rosuvastatin is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Rosuvastatin is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Rosuvastatin
Back to top
Previous Drug Generic - Next Drug Generic